INIS
heparin
100%
patients
54%
reviews
51%
electrodes
47%
nanoparticles
47%
concentration
42%
risks
37%
plasma
37%
performance
35%
data
35%
drugs
31%
assessments
28%
anticoagulants
26%
silver
26%
aggregation
26%
mass spectrometry
23%
fibrinolysis
23%
adhesion
23%
light transmission
23%
myocardial infarction
23%
validation
23%
serotonin
23%
lysis
23%
reactivity
23%
hemolysis
23%
erythrocytes
23%
liquid column chromatography
23%
mortality
23%
values
21%
blood
18%
applications
14%
blood coagulation
14%
doses
12%
ionization
11%
spectrophotometry
11%
thrombin
11%
hemoglobin
11%
scanning electron microscopy
11%
spectra
11%
laboratories
11%
availability
10%
inclusions
9%
bids
9%
information
8%
surgery
7%
manufacturers
7%
comparative evaluations
6%
curves
6%
control
6%
medicines
5%
Keyphrases
Major Bleeding
23%
Cardiovascular Events
23%
Systematic Meta-analysis
23%
All-cause Mortality
23%
Meta-analysis of Randomized Controlled Trials
23%
Heparin-induced Thrombocytopenia
23%
AcuStar
23%
Heparin-induced multiple Electrode Aggregometry
23%
Platelet-derived Microparticles
23%
Euglobulin Clot Lysis Time
23%
Serotonin Release Assay
15%
Fixed Effects Model
14%
Routine Monitoring
11%
Drug Approval
11%
Platelet Adhesion
11%
Unfractionated Heparin
11%
Heparin Concentration
7%
Hemoglobin Release
5%
Antimicrobial Spectrum
5%
Procoagulant Potential
5%
Blood Elements
5%
Electrospray Ionization
5%
Bioanalytical Method Validation
5%
Precision Accuracy
5%
Single Run
5%
Platelet Response
5%
Good Responders
5%
Carry-over Effects
5%
Platelet Secretion
5%
European Medicines Agency Guideline
5%
Tandem Mass Spectrometer
5%